Gherzon Casanova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gherzon Casanova has a total of 44 co-authors. Here are the top co-authors by number of shared publications:
- Begoña González-Suárez
Hospital Clínic de Barcelona ICMiD, N/A, Spain
6 shared publications - Miguel Urpí-Ferreruela
Hospital Clinic de Barcelona, Barcelona, Spain
5 shared publications - Gloria Fernández-Esparrach
Endoscopy Unit, Gastroenterology Department, ICMDM, Hospital Clinic, UB, C/Villarroel 170, 08036 Barcelona, Spain
3 shared publications - Angels Ginès
Hospital Clinic de Barcelona, Barcelona, Spain
2 shared publications - Antonio Giordano
Temple University
2 shared publications - Elena Ricart
Servicio de Aparato Digestivo Hospital Clínic Barcelona Spain
2 shared publications
Latest Publications
- Open Access
- 24 July 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (8) , 1807
The Role of Gut Microbiota in Gastrointestinal Immune Homeostasis and Inflammation: Implications for Inflammatory Bowel Disease
Inflammatory bowel disease (IBD), a heterogeneous group of recurring inflammatory conditions of the digestive system that encompass both ulcerative colitis (UC) and Crohn’s disease (CD), pose a significant public health challenge, currently lacking a definitive cure. The specific etiopathogenesis of IBD is not yet fully understood, but a multifactorial interplay of genetic and environmental factors is suspected. A growing body of evidence supports the involvement of intestinal dysbiosis in the development of IBD, including the effects of dysbiosis on the integrity of the intestinal epithelial barrier, modulation of the host immune system, alterations in the enteric nervous system, and the perpetuation of chronic inflammation. A comprehensive understanding of these mechanisms is important to define preventive measures, to develop new effective and lasting treatments, and to improve disease outcome. This review examines the complex tri-directional relationship between gut microbiota, mucosal immune system, and intestinal epithelium in IBD. In addition, nonpharmacological and behavioral strategies aimed at restoring a proper microbial–immune relationship will be suggested.
- 24 July 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (8) , 1807
Open AccessThe Role of Gut Microbiota in Gastrointestinal Immune Homeostasis and Inflammation: Implications for Inflammatory Bowel Disease
Inflammatory bowel disease (IBD), a heterogeneous group of recurring inflammatory conditions of the digestive system that encompass both ulcerative colitis (UC) and Crohn’s disease (CD), pose a significant public health challenge, currently lacking a definitive cure. The specific etiopathogenesis of IBD is not yet fully understood, but a multifactorial interplay of genetic and environmental factors is suspected. A growing body of evidence supports the involvement of intestinal dysbiosis in the development of IBD, including the effects of dysbiosis on the integrity of the intestinal epithelial barrier, modulation of the host immune system, alterations in the enteric nervous system, and the perpetuation of chronic inflammation. A comprehensive understanding of these mechanisms is important to define preventive measures, to develop new effective and lasting treatments, and to improve disease outcome. This review examines the complex tri-directional relationship between gut microbiota, mucosal immune system, and intestinal epithelium in IBD. In addition, nonpharmacological and behavioral strategies aimed at restoring a proper microbial–immune relationship will be suggested.
- 22 September 2023
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 99 (2) , 283-284
Endoscopic diagnosis of a neuroendocrine neoplasm inside a Meckel’s diverticulum: a capsule endoscopy finding
- 22 September 2023
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 99 (2) , 283-284
Endoscopic diagnosis of a neuroendocrine neoplasm inside a Meckel’s diverticulum: a capsule endoscopy finding
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S43-S44
Comparison Of An Artificial Intelligence Capsule Endoscopy System (Navicam) with the conventional Capsule Endoscopy (Pillcam Sb3) In The Study Of Small Bowel Pathology: Navipill Pilot Study
Aims Artificial intelligence can improve reading times and lesion detection rates in Small Bowel Capsule Endoscopy (SBCE).Compare the reading with artificial intelligence (AIR) of the Navicam Capsule with the conventional reading (CR) of PillcamR SB3 (gold standard). Methods Prospective clinical trial comparing AIR and CR (non-inferiority study). The 2 SBCE were administered to the same patient in randomized order with 60-minute intervals. AIR and CR were performed by two independent expert investigators. Diagnostic performance (percentage of lesions compatible with the indication for the test), diagnostic accuracy and reading times of the AIR compared to CR were evaluated. Results Twenty patients (median age 60 ± 10 years) were included. SBCE studies were complete with Navicam and Pillcam in 100% and 95% (p=1). The diagnostic yield by AIR and CR was 80% and 90% (p=0.5). The two readings agreed in 90% of the cases (Cohen's k 0.62). In the analysis per patient, the AIR presented sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and diagnostic accuracy of 88%, 100%, 100%, 60%, and 90%, respectively. In the analysis per lesion, the AIR showed sensitivity, specificity, PPV, NPV, and diagnostic accuracy of 97%, 50%, 95%, 60%, and 93%, respectively. Mean reading time was 3.2 ±3.9 minutes with AIR and 27.5 ±9. 4 minutes with CR (p < 0.001). Conclusions AIR with NavicamR shows high agreement with CR with PillcamR. AI demonstrates high diagnostic yield and accuracy, with a significant reduction of reading times. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S43-S44
Comparison Of An Artificial Intelligence Capsule Endoscopy System (Navicam) with the conventional Capsule Endoscopy (Pillcam Sb3) In The Study Of Small Bowel Pathology: Navipill Pilot Study
Aims Artificial intelligence can improve reading times and lesion detection rates in Small Bowel Capsule Endoscopy (SBCE).Compare the reading with artificial intelligence (AIR) of the Navicam Capsule with the conventional reading (CR) of PillcamR SB3 (gold standard). Methods Prospective clinical trial comparing AIR and CR (non-inferiority study). The 2 SBCE were administered to the same patient in randomized order with 60-minute intervals. AIR and CR were performed by two independent expert investigators. Diagnostic performance (percentage of lesions compatible with the indication for the test), diagnostic accuracy and reading times of the AIR compared to CR were evaluated. Results Twenty patients (median age 60 ± 10 years) were included. SBCE studies were complete with Navicam and Pillcam in 100% and 95% (p=1). The diagnostic yield by AIR and CR was 80% and 90% (p=0.5). The two readings agreed in 90% of the cases (Cohen's k 0.62). In the analysis per patient, the AIR presented sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and diagnostic accuracy of 88%, 100%, 100%, 60%, and 90%, respectively. In the analysis per lesion, the AIR showed sensitivity, specificity, PPV, NPV, and diagnostic accuracy of 97%, 50%, 95%, 60%, and 93%, respectively. Mean reading time was 3.2 ±3.9 minutes with AIR and 27.5 ±9. 4 minutes with CR (p < 0.001). Conclusions AIR with NavicamR shows high agreement with CR with PillcamR. AI demonstrates high diagnostic yield and accuracy, with a significant reduction of reading times. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S254
Prospective and comparative observational study between Single-Balloon Enteroscopy and Motorized Spiral Enteroscopy
Aims Motorized Spiral Enteroscopy (MSE) emerged as a technique with higher insertion depth and shorter exploration time. However, comparative studies with previous techniques are scarce. We aimed to compare Single-Balloon Enteroscopy (SBE) and MSE efficacy and safety. Methods Prospective and comparative observational study conducted on patients undergoing SBE or MSE in a tertiary hospital from December 2019 to July 2022. Demographic characteristics, procedure indication, small bowel exploration time (SBET), technical success, depth of maximum insertion (DMI), diagnostic, therapeutic, interventional yield and adverse events (AE), were collected. Data was analyzed using IBM SPSS Statistics 28.0 [1] [2] [3] [4] [5]. Results A total of 323 enteroscopies (152 SBE and 171 MSE) were performed in 267 patients. Suspected small bowel bleeding was the most frequent indication (72.2%). Insertion was anterograde in 213 cases (123 SBE/ 90 MSE) and retrograde in 110 cases (29 SBE/ 81 MSE). Technical success was 98% with SBE and 92.35% with EMS (p=0.019), performing complete enteroscopies only with MSE (0% vs 10.4%, p<0.001). For the anterograde route, SBE showed significantly lower DMI than MSE (229.80+/-86.32cm vs 430.55+/-211.98cm, p<0.001). No statistical differences were found regarding SBET (39min vs 34.22min, pNS). The diagnostic yield was 72.3% and 65% (pNS), the therapeutic yield was 63.8% and 40.9% (p<0.001), and interventional yield was 86.8% and 68.4% for SBE and MSE, respectively (p<0.001). No differences were found regarding AE rate (4.6% vs 9.3%, pNS). Conclusions Both techniques, SBE and MSE, are effective and safe. SBE has better performance in the therapeutic and interventional yield. MSE allows a higher DMI for the anterograde route. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 14 April 2023
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 55 (S 02) , S254
Prospective and comparative observational study between Single-Balloon Enteroscopy and Motorized Spiral Enteroscopy
Aims Motorized Spiral Enteroscopy (MSE) emerged as a technique with higher insertion depth and shorter exploration time. However, comparative studies with previous techniques are scarce. We aimed to compare Single-Balloon Enteroscopy (SBE) and MSE efficacy and safety. Methods Prospective and comparative observational study conducted on patients undergoing SBE or MSE in a tertiary hospital from December 2019 to July 2022. Demographic characteristics, procedure indication, small bowel exploration time (SBET), technical success, depth of maximum insertion (DMI), diagnostic, therapeutic, interventional yield and adverse events (AE), were collected. Data was analyzed using IBM SPSS Statistics 28.0 [1] [2] [3] [4] [5]. Results A total of 323 enteroscopies (152 SBE and 171 MSE) were performed in 267 patients. Suspected small bowel bleeding was the most frequent indication (72.2%). Insertion was anterograde in 213 cases (123 SBE/ 90 MSE) and retrograde in 110 cases (29 SBE/ 81 MSE). Technical success was 98% with SBE and 92.35% with EMS (p=0.019), performing complete enteroscopies only with MSE (0% vs 10.4%, p<0.001). For the anterograde route, SBE showed significantly lower DMI than MSE (229.80+/-86.32cm vs 430.55+/-211.98cm, p<0.001). No statistical differences were found regarding SBET (39min vs 34.22min, pNS). The diagnostic yield was 72.3% and 65% (pNS), the therapeutic yield was 63.8% and 40.9% (p<0.001), and interventional yield was 86.8% and 68.4% for SBE and MSE, respectively (p<0.001). No differences were found regarding AE rate (4.6% vs 9.3%, pNS). Conclusions Both techniques, SBE and MSE, are effective and safe. SBE has better performance in the therapeutic and interventional yield. MSE allows a higher DMI for the anterograde route. Article published online: 14 April 2023 © 2023. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 15 September 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (9) , 2226
Fecal Calprotectin for Small Bowel Crohn’s Disease: Is It a Cutoff Issue?
(1) Background: Fecal calprotectin (FC) correlates well with colonic inflammatory activity of Crohn’s disease (CD); data about relation of FC and small bowel (SB) lesions are still contradictory. The main aim was to analyze the relationship between FC levels and SB inflammatory activity in patients with established or suspected Crohn’s disease, assessed by small bowel capsule endoscopy (SBCE) or magnetic resonance enterography (MRE). (2) Methods: Two cohorts of patients were included: 1. Prospective data were collected from patients with established or suspected CD who underwent SBCE and FC (Cohort A); 2. A retrospective cohort of patients who underwent MRE and FC determination (Cohort B). Different cutoffs for FC were tested in both cohorts. (3) Results: 83 patients were included and 66 were finally analyzed. A total of 69.6% had SB lesions seen by SBCE (n = 25) or MRE (n = 21). FC mean levels were 605.74 + 607.07 μg/g (IQ range: 99.00–878.75), being significantly higher in patients with SB lesions compared to patients without lesions (735.91 + 639.70 μg/g (IQ range: 107.75–1366.25) vs. 306.35 + 395.26 μg/g (IQ range: 78.25–411.0), p < 0.005). For cohort A, 25 out of 35 patients had SB lesions and a significant correlation between Lewis Score and FC levels was achieved (R2: 0.34; p = 0.04). FC sensitivity (S), specificity (E), positive predictive value (PPV), and negative predictive values (NPV) for predicting SB lesions were 80%, 50%, 80%, and 50%, respectively, for FC > 100 µg/g. For cohort B, inflammatory SB activity, measured by MaRIA score, was detected in 21 out of 31 patients (67.7%). Patients with positive findings in MRE had significantly higher values of FC than those with no lesions (944.9 + 672.1 µg/g vs. 221 + 212.2 µg/g, p < 0.05). S, E, PPV, and NPV of FC were 89%, 50%, 77.2%, and 71.4% for FC levels > 100 µg/g. The higher sensitivity and specificity of the FC levels for the detection of SB lesions with SBCE and MRE was obtained for an FC cutoff >265 μg/g and >430 μg/g, respectively. (4) Conclusions: FC has a good correlation with the presence of SB lesions, assessed by SBCE and MRE, in patients with established or suspected Crohn’s disease. However, the ideal cutoff is here proven to be higher than previously reported. Multicenter and large prospective studies are needed in order to establish definitive FC cutoff levels.
- 15 September 2022
- Published by MDPI AG in Diagnostics
- Vol. 12 (9) , 2226
Open AccessFecal Calprotectin for Small Bowel Crohn’s Disease: Is It a Cutoff Issue?
(1) Background: Fecal calprotectin (FC) correlates well with colonic inflammatory activity of Crohn’s disease (CD); data about relation of FC and small bowel (SB) lesions are still contradictory. The main aim was to analyze the relationship between FC levels and SB inflammatory activity in patients with established or suspected Crohn’s disease, assessed by small bowel capsule endoscopy (SBCE) or magnetic resonance enterography (MRE). (2) Methods: Two cohorts of patients were included: 1. Prospective data were collected from patients with established or suspected CD who underwent SBCE and FC (Cohort A); 2. A retrospective cohort of patients who underwent MRE and FC determination (Cohort B). Different cutoffs for FC were tested in both cohorts. (3) Results: 83 patients were included and 66 were finally analyzed. A total of 69.6% had SB lesions seen by SBCE (n = 25) or MRE (n = 21). FC mean levels were 605.74 + 607.07 μg/g (IQ range: 99.00–878.75), being significantly higher in patients with SB lesions compared to patients without lesions (735.91 + 639.70 μg/g (IQ range: 107.75–1366.25) vs. 306.35 + 395.26 μg/g (IQ range: 78.25–411.0), p < 0.005). For cohort A, 25 out of 35 patients had SB lesions and a significant correlation between Lewis Score and FC levels was achieved (R2: 0.34; p = 0.04). FC sensitivity (S), specificity (E), positive predictive value (PPV), and negative predictive values (NPV) for predicting SB lesions were 80%, 50%, 80%, and 50%, respectively, for FC > 100 µg/g. For cohort B, inflammatory SB activity, measured by MaRIA score, was detected in 21 out of 31 patients (67.7%). Patients with positive findings in MRE had significantly higher values of FC than those with no lesions (944.9 + 672.1 µg/g vs. 221 + 212.2 µg/g, p < 0.05). S, E, PPV, and NPV of FC were 89%, 50%, 77.2%, and 71.4% for FC levels > 100 µg/g. The higher sensitivity and specificity of the FC levels for the detection of SB lesions with SBCE and MRE was obtained for an FC cutoff >265 μg/g and >430 μg/g, respectively. (4) Conclusions: FC has a good correlation with the presence of SB lesions, assessed by SBCE and MRE, in patients with established or suspected Crohn’s disease. However, the ideal cutoff is here proven to be higher than previously reported. Multicenter and large prospective studies are needed in order to establish definitive FC cutoff levels.
- Open Access
- 14 September 2022
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 68 (4) , 1447-1454
Motorized Spiral Enteroscopy Is Effective in Patients with Prior Abdominal Surgery
Background Motorized Spiral Enteroscopy (MSE) reduces procedure time and increases insertion depth into the small bowel; however, there is scarce evidence on factors affecting MSE efficacy. Aims To evaluate diagnostic yield and adverse events of MSE including patients with prior major abdominal surgery. Methods A prospective observational study was conducted on patients undergoing MSE from June 2019 to December 2021. Demographic characteristics, procedure time, depth of maximum insertion (DMI), technical success, diagnostic yield, and adverse events were collected. Results Seventy-four anterograde (54.4%) and 62 retrograde (45.6%) enteroscopies were performed in 117 patients (64 males, median age 67 years). Fifty patients (42.7%) had prior major abdominal surgery. Technical success was 91.9% for anterograde and 90.3% for retrograde route. Diagnostic yield was 71.6% and 61.3%, respectively. The median DMI was 415 cm (264–585) for anterograde and 120 cm (37–225) for retrograde enteroscopy. In patients with prior major abdominal surgery, MSE showed significantly longer small bowel insertion time (38 vs 29 min, p = 0.004), with similar diagnostic yield (61 vs 71.4%, p = 0.201) and DMI (315 vs 204 cm, p = 0.226). The overall adverse event rate was 10.3% (SAE 1.5%), with no differences related to prior abdominal surgery (p = 0.598). Patients with prior surgeries directly involving the gastrointestinal tract showed lower DMI (189 vs 374 cm, p = 0.019) with equal exploration time (37.5 vs 38 min, p = 0.642) compared to those with other abdominal surgeries. Conclusions MSE is effective and safe in patients with major abdominal surgery, although longer procedure times were observed. A lower depth of insertion was detected in patients with gastrointestinal surgery.
- 14 September 2022
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 68 (4) , 1447-1454
Open AccessMotorized Spiral Enteroscopy Is Effective in Patients with Prior Abdominal Surgery
Background Motorized Spiral Enteroscopy (MSE) reduces procedure time and increases insertion depth into the small bowel; however, there is scarce evidence on factors affecting MSE efficacy. Aims To evaluate diagnostic yield and adverse events of MSE including patients with prior major abdominal surgery. Methods A prospective observational study was conducted on patients undergoing MSE from June 2019 to December 2021. Demographic characteristics, procedure time, depth of maximum insertion (DMI), technical success, diagnostic yield, and adverse events were collected. Results Seventy-four anterograde (54.4%) and 62 retrograde (45.6%) enteroscopies were performed in 117 patients (64 males, median age 67 years). Fifty patients (42.7%) had prior major abdominal surgery. Technical success was 91.9% for anterograde and 90.3% for retrograde route. Diagnostic yield was 71.6% and 61.3%, respectively. The median DMI was 415 cm (264–585) for anterograde and 120 cm (37–225) for retrograde enteroscopy. In patients with prior major abdominal surgery, MSE showed significantly longer small bowel insertion time (38 vs 29 min, p = 0.004), with similar diagnostic yield (61 vs 71.4%, p = 0.201) and DMI (315 vs 204 cm, p = 0.226). The overall adverse event rate was 10.3% (SAE 1.5%), with no differences related to prior abdominal surgery (p = 0.598). Patients with prior surgeries directly involving the gastrointestinal tract showed lower DMI (189 vs 374 cm, p = 0.019) with equal exploration time (37.5 vs 38 min, p = 0.642) compared to those with other abdominal surgeries. Conclusions MSE is effective and safe in patients with major abdominal surgery, although longer procedure times were observed. A lower depth of insertion was detected in patients with gastrointestinal surgery.
- 1 December 2020
- Published by Elsevier in Journal of Hepatology
- Vol. 73 (6) , 1360-1367
Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions by 2025
- 1 December 2020
- Published by Elsevier in Journal of Hepatology
- Vol. 73 (6) , 1360-1367
Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions by 2025